Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Docetaxel Upregulates HMGB1 Levels in Non-small Cell Lung Cancer.

Biological & pharmaceutical bulletin - 1 Jan 2020

Haruna Miya, Hirata Michinari, Iwahori Kota, Kanazawa Takayuki, Yamamoto Yoko, Goto Kumiko, Kawashima Atsunari, Morimoto-Okazawa Akiko, Funaki Soichiro, Shintani Yasushi, Kumanogoh Atsushi, Wada Hisashi

Abstract excerpt

Immune checkpoint inhibitors (ICIs) exert beneficial effects in non-small cell lung cancer (NSCLC) patients. However, ICIs are only advantageous for a limited population of NSCLC patients. Therefore to enhance their effects, combination therapies with ICIs have been developed. To identify preferable chemotherapy to combine with ICIs against lung cancer, we examined immunological effects of docetaxel compared with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to A549 Cells
Share to CD11 Antigens

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chemokines

Share to Combined Modality Therapy

Share to Docetaxel

Share to Epidermal Growth Factor

Share to HMGB1 Protein

Share to Integrin alpha Chains

Source

Identifiers

PMID: 32115500
DOI: 10.1248/bpb.b19-00702

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Docetaxel Upregulates HMGB1 Levels in Non-small Cell Lung Cancer.PMID 32115500Read ↗

HMGB1-mediated autophagy promotes docetaxel resistance in human lung adenocarcinomaSemantic proximity Read ↗

Systematic analysis of expression profiles of HMGB family members for prognostic application in non-small cell lung cancerSemantic proximity Read ↗

Effects of PD-1, HMGB1 and LFA-1 polymorphisms on non-small cell lung cancer susceptibilitySemantic proximity Read ↗

Docetaxel enhances CD3+ CD56+ cytokine-induced killer cells-mediated killing through inducing tumor cells phenotype modulation.Semantic proximity Read ↗

Exploratory Analysis of HMGB1 Genetic Variants and Their Potential Association with Lung Cancer Susceptibility and Chemotherapy Response in a Chinese Population.Semantic proximity Read ↗

Association of HMGB1 and HMGB2 genetic polymorphisms with lung cancer chemotherapy response.Semantic proximity Read ↗

Multiple functions of HMGB1 in cancerSemantic proximity Read ↗

Targeting the STAT5A/IDO1 axis overcomes radioresistance and reverses the immunosuppressive tumor microenvironment in NSCLCSemantic proximity Read ↗

Synergy of nanodiamond-doxorubicin conjugates and PD-L1 blockade effectively turns tumor associated macrophages against tumor cellsSemantic proximity Read ↗

Association of HMGB1 Gene Polymorphisms with Lung Cancer Susceptibility and Clinical Aspects.Semantic proximity Read ↗

HMGB1 promotes chemoresistance in small cell lung cancer by inducing PARP1-related nucleophagySemantic proximity Read ↗

HMGB1 as a Potential Biomarker and Therapeutic Target for Malignant MesotheliomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.